147 related articles for article (PubMed ID: 22222189)
1. Risk of post-lung transplant renal dysfunction in adults with cystic fibrosis.
Quon BS; Mayer-Hamblett N; Aitken ML; Goss CH
Chest; 2012 Jul; 142(1):185-191. PubMed ID: 22222189
[TBL] [Abstract][Full Text] [Related]
2. An aging population of patients with cystic fibrosis undergoes lung transplantation: An analysis of the ISHLT Thoracic Transplant Registry.
Benden C; Goldfarb SB; Stehlik J
J Heart Lung Transplant; 2019 Nov; 38(11):1162-1169. PubMed ID: 31353276
[TBL] [Abstract][Full Text] [Related]
3. Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation: A United Network for Organ Sharing Registry Study.
Ramos KJ; Kapnadak SG; Bradford MC; Somayaji R; Morrell ED; Pilewski JM; Lease ED; Mulligan MS; Aitken ML; Gries CJ; Goss CH
Chest; 2020 Apr; 157(4):898-906. PubMed ID: 31958441
[TBL] [Abstract][Full Text] [Related]
4. Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis.
Stephenson AL; Sykes J; Berthiaume Y; Singer LG; Aaron SD; Whitmore GA; Stanojevic S
J Heart Lung Transplant; 2015 Sep; 34(9):1139-45. PubMed ID: 26087666
[TBL] [Abstract][Full Text] [Related]
5. Recipient Age Impacts Long-Term Survival in Adult Subjects with Cystic Fibrosis after Lung Transplantation.
Sethi J; Bugajski A; Patel KN; Davis NM; Wille KM; Qureshi MR; Banday MM; Lin M; Emani V; Weill D; Tumin D; Hayes D; Jr ; Sharma NS
Ann Am Thorac Soc; 2021 Jan; 18(1):44-50. PubMed ID: 32795188
[No Abstract] [Full Text] [Related]
6. Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV
Ramos KJ; Quon BS; Heltshe SL; Mayer-Hamblett N; Lease ED; Aitken ML; Weiss NS; Goss CH
Chest; 2017 Jun; 151(6):1320-1328. PubMed ID: 28115168
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of PTLD in lung transplant recipients with cystic fibrosis.
Lowery EM; Adams W; Grim SA; Clark NM; Edwards L; Layden JE
J Cyst Fibros; 2017 Nov; 16(6):727-734. PubMed ID: 28456611
[TBL] [Abstract][Full Text] [Related]
8. Impact of lung allocation score on survival in cystic fibrosis lung transplant recipients.
Braun AT; Dasenbrook EC; Shah AS; Orens JB; Merlo CA
J Heart Lung Transplant; 2015 Nov; 34(11):1436-41. PubMed ID: 26212659
[TBL] [Abstract][Full Text] [Related]
9. Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation.
Hayes D; Patel AV; Black SM; McCoy KS; Kirkby S; Tobias JD; Mansour HM; Whitson BA
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):707-13.e2. PubMed ID: 26208890
[TBL] [Abstract][Full Text] [Related]
10. Lung transplantation for cystic fibrosis: differential characteristics and outcomes between children and adults.
Moreno P; Alvarez A; Carrasco G; Redel J; Guaman HD; Baamonde C; Algar FJ; Cerezo F; Salvatierra A
Eur J Cardiothorac Surg; 2016 May; 49(5):1334-43. PubMed ID: 26530270
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for chronic kidney disease in adults with cystic fibrosis.
Quon BS; Mayer-Hamblett N; Aitken ML; Smyth AR; Goss CH
Am J Respir Crit Care Med; 2011 Nov; 184(10):1147-52. PubMed ID: 21799076
[TBL] [Abstract][Full Text] [Related]
12. Impaired Renal Function Should Not Be a Barrier to Transplantation in Patients With Cystic Fibrosis.
Crawford TC; Magruder JT; Grimm JC; Suarez-Pierre A; Zhou X; Ha JS; Higgins RS; Broderick SR; Orens JB; Shah P; Merlo CA; Kim BS; Bush EL
Ann Thorac Surg; 2017 Oct; 104(4):1231-1236. PubMed ID: 28822537
[TBL] [Abstract][Full Text] [Related]
13. Effect of Including Important Clinical Variables on Accuracy of the Lung Allocation Score for Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Lehr CJ; Skeans M; Dasenbrook E; Fink A; Fernandez G; Faro A; Valapour M
Am J Respir Crit Care Med; 2019 Oct; 200(8):1013-1021. PubMed ID: 31199166
[No Abstract] [Full Text] [Related]
14. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients.
Helmi M; Love RB; Welter D; Cornwell RD; Meyer KC
Chest; 2003 Mar; 123(3):800-8. PubMed ID: 12628881
[TBL] [Abstract][Full Text] [Related]
15. Transplant center volume and outcomes in lung transplantation for cystic fibrosis.
Hayes D; Sweet SC; Benden C; Kopp BT; Goldfarb SB; Visner GA; Mallory GB; Tobias JD; Tumin D
Transpl Int; 2017 Apr; 30(4):371-377. PubMed ID: 28012223
[TBL] [Abstract][Full Text] [Related]
16. Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis.
Hirama T; Tomiyama F; Notsuda H; Watanabe T; Watanabe Y; Oishi H; Okada Y
BMC Pulm Med; 2021 Aug; 21(1):261. PubMed ID: 34384425
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in cystic fibrosis lung transplant recipients infected with organisms labeled as pan-resistant: An ISHLT Registry‒based analysis.
Lay C; Law N; Holm AM; Benden C; Aslam S
J Heart Lung Transplant; 2019 May; 38(5):545-552. PubMed ID: 30733155
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Predictors of Reduced Survival for Adult-diagnosed Cystic Fibrosis. Analysis of the Canadian CF Registry.
Desai S; Wong H; Sykes J; Stephenson AL; Singer J; Quon BS
Ann Am Thorac Soc; 2018 Oct; 15(10):1177-1185. PubMed ID: 29944384
[TBL] [Abstract][Full Text] [Related]
19. Lung transplantation for cystic fibrosis.
Yeung JC; Machuca TN; Chaparro C; Cypel M; Stephenson AL; Solomon M; Saito T; Binnie M; Chow CW; Grasemann H; Pierre AF; Yasufuku K; de Perrot M; Donahoe LL; Tikkanen J; Martinu T; Waddell TK; Tullis E; Singer LG; Keshavjee S
J Heart Lung Transplant; 2020 Jun; 39(6):553-560. PubMed ID: 32147452
[TBL] [Abstract][Full Text] [Related]
20. Pre-transplant Panel Reactive Antibody and Survival in Adult Cystic Fibrosis Patients After Lung Transplantation.
Hayes D; Tumin D; Tobias JD
Lung; 2016 Jun; 194(3):429-35. PubMed ID: 26932810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
